Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Orexigen Therapeutics Inc (OREXQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Orexigen Therapeutics historical data, for real-time data please try another search
0.005 0.000    0.00%
31/05 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.003 - 0.005
Type:  Equity
Market:  United States
Orexigen Therapeutics 0.005 0.000 0.00%

OREXQ Share Price Overview

 
Assess today's live Orexigen Therapeutics Inc (OREXQ) share price, performance and insights using our live OTC Markets: OREXQ stock exchange data.

Analyse the historical data and Orexigen Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Orexigen Therapeutics share price buy/sell indicators using real-time data (or discuss the Orexigen Therapeutics (OREXQ) stock price today with other investors in the Orexigen Therapeutics OTC share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current OTC OREXQ share price (ISIN: US6861643020) to enhance your trading decisions with our free investment tools and resources.

What Is the Orexigen Therapeutics Inc Share Price Today?
The Orexigen Therapeutics share price today is 0.005.

What Is the Stock Symbol for Orexigen Therapeutics Inc
The stock symbol (or 'ticker') for Orexigen Therapeutics Inc is "OREXQ."

What Stock Exchange Does Orexigen Therapeutics Inc Trade On?
Orexigen Therapeutics Inc is listed and trades on the OTC Markets stock exchange.

Is Orexigen Therapeutics Inc a Good Stock to Buy?
Determining whether Orexigen Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.004
Day's Range0.003 - 0.005
RevenueN/A
Open0.003
52 wk Range0 - 0
EPS - 9.7
VolumeN/A
Market Cap100.1K
Dividend (Yield)N/A (N/A)
Average Volume (3m)469,115
P/E RatioN/A
Beta10.99
1-Year Change0%
Shares Outstanding18,887,033
Next Earnings DateN/A
What is your sentiment on Orexigen Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Orexigen Therapeutics Inc News Today


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Buy Sell Strong Sell
Technical Indicators BUY BUY BUY Sell Strong Sell
Summary Buy Buy Buy Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bullish 1H Current
Bullish Engulfing 1H Current
Belt Hold Bullish 5H Current
Bullish Engulfing 5H Current
Belt Hold Bullish 1D Current
Three Outside Up 1D Current
Belt Hold Bullish 1W Current
Bullish Engulfing 1W Current
Completed Patterns
Tri-Star Bullish 1H 0 May 28, 2019 19:00
Bullish Engulfing 1D 1 May 30, 2019
Morning Doji Star 1D 1 May 30, 2019

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  IAG 178.65 181.20 177.50 +0.35 +0.20% 14.83M  
  HSBC 705.50 714.40 705.00 +0.50 +0.07% 16.83M  
  BP 510.40 516.70 506.10 -5.40 -1.05% 26.15M  
  Rolls-Royce Holdings 418.10 418.10 408.50 +11.60 +2.85% 13.15M  
  AstraZeneca 12,050.0 12,178.0 12,010.0 -106.0 -0.87% 1.64M  
  British American Tobacco 2,355.0 2,387.0 2,355.0 -16.0 -0.68% 4.18M  
  Vodafone Group PLC 68.440 68.760 67.800 +0.620 +0.91% 88.26M  
  Lloyds Banking 52.18 52.92 52.18 +0.12 +0.23% 86.28M  
  Legal & General 240.90 241.90 237.00 +5.10 +2.16% 9.56M  
  Glencore 455.00 457.84 449.30 -3.70 -0.81% 25.91M  

%SHORT_NAME% Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

132

Equity Type

ORD

On May 31, 2019, Orexigen Therapeutics, Inc., went out of business as per its Chapter 11 liquidation filing under bankruptcy. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OREXQ Price Commentary

Write your thoughts about Orexigen Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email